The research report titled ‘Endotherapy Devices Market Size By Product (Gastrointestinal (GI) Devices & Accessories {Biopsy Forceps [Single-use Biopsy Forceps, Reusable Biopsy Forceps, Hot Biopsy Forceps], Injection Needles [EUS-guided FNA Needles, EUS-guided FNB Needles], Polypectomy Snares, Graspers, Hemoclips, Endoscopic Submucosal Dissection (ESD) Knives [Insulation-tipped Knives, Needle-tipped Knives], Hemostasis Forceps, Sclerotherapy Needle}, Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices & Accessories {Guide Wire, Sphincterotome, Catheter [Drainage Catheter, Dilation Catheter, Guiding Catheter], Extraction Basket, Extraction Balloon, Balloon Dilation, Plastic Stents, Metal Stents}), By End-use (Hospitals, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028’, available with MarketStudyReport, endotherapy devices market size is estimated to garner substantial returns by 2028.

Rising geriatric population, and growing inclination towards minimally invasive surgical procedures are the factors boosting endotherapy devices market trends.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4887084/  

In addition, prevalence of diseases like chronic pancreatitis, and steady technological advancements in pancreatic endotherapy may unearth new avenues for market expansion in the upcoming years.  Notably, endoscopic devices provide instant pain relief to patients suffering with chronic pancreatitis as these devices make use of minimally invasive surgical techniques that minimize complications.

Based on product type, the endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories segment is slated to record a CAGR Of 8.4% and accumulate substantial returns by 2028, attributable to the immense success rate of ERCP procedures, coupled with greater compatibility.

Speaking of end-user scope, the ambulatory surgical centers sub-segment of endotherapy devices industry is anticipated to amass a valuation of USD 2092 million by the forecast period end, creditable to rising consumer preference for these settings as they provide higher quality services, while simultaneously being affordable in nature.

From a regional standpoint, Middle East & Africa market, which garnered a renumeration of USD 80 million in 2021, is expected to gain considerable momentum during the review period, ascribed to increasing occurrence of gastrointestinal disorders and widespread product uptake for treatment.

The competitive terrain of endotherapy devices marketplace is majorly influenced by key players including M.I. Tech Co. Ltd., Taewoong Medical Co. Ltd., Micro-Tech (Nanjing) Co. Ltd., Johnson & Johnson Consumer Companies Inc., Karl Storz SE & Co. KG, Medtronic plc, Conmed Corporation, Fujifilm Corporation, Boston Scientific Corporation, Cook Medical Inc., and Olympus Corporation.

These companies are undertaking various partnership deals, acquisitions and mergers, while directing efforts to improve their production capacity to maintain a strong foothold over market dynamics.

For instance, Cook Medical Inc., a renowned minimally invasive medical devices provider, launched its novel endoscopic clipped device named Instinct Plus Endoscopic Clipping Device in January 2022 with the aim to improve clip handling and facilitate smoother operation.